Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Care topic
No spam. Unsubscribe anytime.
House approves step‑therapy bill sponsors say will help cancer patients
Summary
The Tennessee House passed House Bill 858 on third and final consideration after sponsor Representative Alexander described the measure as a two‑year effort with oncologists to address step‑therapy barriers for patients with metastatic cancer; the vote was recorded as 94 ayes.
The Tennessee House of Representatives passed House Bill 858 on third and final consideration on April 2, 2025.
Representative Alexander, the bill’s sponsor, framed the measure as targeted to patients with advanced cancer and said he and oncologists had worked for two years on the legislation. "Every one of us knows someone with cancer," Alexander said on the floor, arguing the bill represented "a tremendous step forward in the health care of this state." He renewed his motion for final passage and the House approved the measure in the floor vote (recorded as Ayes 94). The Clerk announced the bill had received a constitutional majority.
Supporters on the floor emphasized the bill’s impact for patients confronting metastatic or stage‑4 disease and described the work with clinical specialists that produced it. No floor amendments were recorded during third consideration, and no sustained debate against the bill was entered on the record.
Why it matters: Sponsors said the measure addresses step‑therapy practices that can delay access to prescribed cancer therapies, and they framed the bill as the product of sustained input from treating oncologists. The transcript records the sponsor’s appeals to urgency and clinical input but does not detail the bill text’s specific step‑therapy changes; language of the enacted measure and implementing guidance will determine how those changes are applied in practice.
What’s next: The House approved the bill and it will proceed according to legislative process (e.g., enrollment, transmission to the Senate or to the governor as appropriate). The transcript does not record additional procedural steps on this floor for the measure beyond final passage.
Provenance: Topic introduced at SEG 702; discussion and final vote concluded at SEG 750.
Speakers quoted or referenced in this article are listed in the meeting speaker roster and were introduced on the House floor (Representative Alexander, sponsor).
